Disclosed are dihydropteridinones of general formula (I) ##STR00001## wherein the groups L and R.sup.1-R.sup.5 have the meanings given in the claims and specification, the pharmaceutical compositions, isomers, intermediates thereof and processes for preparing these dihydropteridinones. The compounds are useful the treatment and/or prevention of cancer, infections, inflammatory and autoimmune diseases.